Associated Papers
Personalizing aromatase inhibitor therapy in patients with breast cancer.
Hamadeh IS et al.
Cancer Treatment Reviews, 2018
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling.
Gelsomino L et al.
Breast Cancer Research and Treatment, 2016
Select a paper to view details